Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1

被引:0
作者
Zhao Yang
Ping Li
Qun Yuan
Xi Wang
Hong-Hong Ma
Bing Zhuan
机构
[1] Suzhou Science & Technology Town Hospital,Department of Respiratory Medicine
[2] The Affiliated Hospital of NingXia Medical University,Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region
来源
Respiratory Research | / 24卷
关键词
Pulmonary hypertension; COPD; PASMC; miR-4640-5p; NOS1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 130 条
[1]  
Farber HW(2004)Pulmonary arterial hypertension N Engl J Med 351 1655-1665
[2]  
Loscalzo J(2008)Pulmonary arterial hypertension J Am Coll Cardiol 51 1527-1538
[3]  
Chin KM(2022)Treatment of pulmonary hypertension associated with COPD: a systematic review ERJ Open Res. 8 00348-2021
[4]  
Rubin LJ(2021)Treatment of pulmonary hypertension associated with COPD: time for another look? Chest 160 409-410
[5]  
Arif R(2022)Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach Chest 162 202-2864
[6]  
Pandey A(2019)New drugs, therapeutic strategies, and future direction for the treatment of pulmonary arterial hypertension Curr Med Chem 26 2844-498
[7]  
Zhao Y(2018)Resident cell lineages are preserved in pulmonary vascular remodeling J Pathol 244 485-171
[8]  
Arsenault-Mehta K(2018)Genome-wide MicroRNA expression profiles in COPD: early predictors for cancer development Genomics Proteomics Bioinformatics 16 162-1749
[9]  
Khoujah D(2014)MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Eur Respir J 43 1740-3790
[10]  
Mehta S(2016)Upregulation of MicroRNA-214 contributes to the development of vascular remodeling in hypoxia-induced pulmonary hypertension via targeting CCNL2 Sci Rep 6 24661-S79